SNT 8.33% 3.9¢ syntara limited

Ann: SNT to present in MST Access Hidden Gems Webinar, page-16

  1. 44 Posts.
    lightbulb Created with Sketch. 17
    The one the market really has no idea about is SNT4728 being studied in prodromal Parkinson's. This drug came back from Boehringer after having amassed data in hundreds of subjects. Hugely derisked from a safety viewpoint.
 
watchlist Created with Sketch. Add SNT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.